SecSonar.com

VolitionRx Limited (VNRX)

VolitionRx Limited at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

VolitionRx Limited (VNRX) is a Medical - Diagnostics & Research company based in US with a market capitalization of $15.6M. Revenue grew 40.0% year-over-year and free cash flow was negative at -$19.8M. This page tracks VNRX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 85 employees · IPO Mar 2, 2012

Valuation

Valuation & price

$2.00 · as of May 17, 2026 · -87.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$15.50$8.37$1.23Jul 25Dec 25Jul 26Jul 7, 25$13.47Jul 9, 25$13.22Jul 11, 25$13.35Jul 15, 25$12.92Jul 17, 25$13.53Jul 21, 25$15.50Jul 23, 25$14.70Jul 25, 25$15.00Jul 29, 25$14.15Jul 31, 25$12.82Aug 4, 25$12.46Aug 6, 25$13.36Aug 11, 25$12.40Aug 13, 25$12.40Aug 15, 25$13.90Aug 19, 25$13.46Aug 21, 25$13.62Aug 25, 25$13.71Aug 27, 25$13.32Aug 29, 25$13.80Sep 3, 25$13.30Sep 5, 25$12.04Sep 9, 25$12.74Sep 11, 25$12.55Sep 16, 25$12.80Sep 18, 25$12.48Sep 22, 25$12.30Sep 24, 25$12.11Sep 26, 25$12.10Sep 30, 25$13.58Oct 2, 25$12.51Oct 6, 25$12.90Oct 8, 25$12.96Oct 10, 25$9.28Oct 14, 25$9.21Oct 16, 25$8.94Oct 21, 25$8.60Oct 23, 25$8.50Oct 27, 25$8.75Oct 29, 25$8.60Oct 31, 25$8.68Nov 4, 25$8.98Nov 6, 25$8.24Nov 10, 25$7.86Nov 12, 25$7.41Nov 14, 25$6.62Nov 18, 25$7.00Nov 20, 25$6.67Nov 25, 25$5.98Nov 28, 25$6.43Dec 2, 25$5.97Dec 4, 25$6.23Dec 8, 25$5.95Dec 10, 25$5.60Dec 12, 25$5.38Dec 16, 25$4.84Dec 18, 25$5.35Dec 22, 25$5.35Dec 24, 25$5.04Dec 29, 25$4.80Jan 2, 26$5.46Jan 6, 26$5.54Jan 8, 26$7.10Jan 12, 26$6.80Jan 14, 26$6.02Jan 16, 26$5.86Jan 21, 26$5.83Jan 23, 26$5.64Jan 27, 26$5.33Jan 29, 26$5.02Feb 2, 26$5.29Feb 4, 26$5.20Feb 9, 26$5.05Feb 11, 26$4.48Feb 13, 26$4.53Feb 18, 26$4.30Feb 20, 26$3.95Feb 24, 26$3.87Feb 26, 26$4.70Mar 2, 26$4.05Mar 4, 26$4.04Mar 6, 26$3.96Mar 10, 26$4.00Mar 12, 26$3.92Mar 17, 26$3.80Mar 19, 26$3.80Mar 23, 26$4.11Mar 25, 26$3.83Mar 27, 26$3.93Mar 31, 26$4.04Apr 2, 26$3.43Apr 7, 26$3.36Apr 9, 26$3.45Apr 13, 26$3.22Apr 15, 26$3.42Apr 17, 26$3.58Apr 22, 26$3.15Apr 24, 26$2.80Apr 28, 26$2.78Apr 30, 26$2.62May 4, 26$2.39May 6, 26$2.49May 8, 26$2.25May 12, 26$2.32May 14, 26$2.20May 18, 26$2.28May 20, 26$2.49May 22, 26$3.13May 28, 26$2.88Jun 1, 26$2.65Jun 3, 26$2.08Jun 5, 26$1.79Jun 9, 26$1.36Jun 11, 26$1.46Jun 15, 26$1.44Jun 17, 26$1.37Jun 22, 26$1.34Jun 24, 26$1.23Jun 26, 26$1.28Jul 2, 26$1.43
$1.2152-week range$15.50
Loading valuation history…

Fundamentals

Key fundamentals

$15.6M

Market cap

40.0%

Revenue growth (YoY)

100.0%

Gross margin

-$19.8M

Free cash flow (USD)

$10.3M

Net debt

23.5%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$0.00FY 2018$0.00FY 2019$17.1KFY 2020$13.4KFY 2021$90.0KFY 2022$306.4KFY 2023$775.3KFY 2024$1.2MFY 2025$1.7M
$0$1.7M

Free cash flow by year

2016 → 2025

FY 2016$-9.5MFY 2017$-13.6MFY 2018$-15.0MFY 2019$-13.3MFY 2020$-18.4MFY 2021$-21.8MFY 2022$-16.8MFY 2023$-19.1MFY 2024$-26.5MFY 2025$-19.8M
-$9.5M-$19.8M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022100.0%FY 2023100.0%FY 2024100.0%FY 2025100.0%
100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $-0.97)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEquity Securities IssuedJun 18, 2026Filing
  • 8-K eventSecurities Purchase AgreementJun 10, 2026Filing
  • 8-K eventWaiver AgreementMay 22, 2026Filing
  • 8-K eventDirector DepartureMay 15, 2026Filing
  • 8-K eventEarnings ReleaseMay 14, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing
  • Annual report10-K FiledApr 30, 2026Filing
  • 8-K eventReverse Stock SplitApr 28, 2026Filing
  • 8-K eventCompliance Plan AcceptedApr 23, 2026Filing
  • 8-K eventReverse Stock SplitApr 17, 2026Filing

Questions

Frequently asked questions

What is VolitionRx Limited's market cap?

VolitionRx Limited (VNRX) has a market capitalization of $15.6M.

What is VNRX's P/E ratio?

A meaningful P/E ratio is not available for VNRX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

When did VolitionRx Limited last report earnings?

VNRX last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying VNRX stock?

SEC Form 4 filings show no open-market insider buys at VolitionRx Limited in the last 90 days (0 sells).

Same arena

Related companies in Medical - Diagnostics & Research

NOTV

Inotiv, Inc.

$9.8M

BIAF

bioAffinity Technologies, Inc.

$7.7M

TRIB

Trinity Biotech plc

$7.4M

BGLC

BioNexus Gene Lab Corp.

$4.4M

INBS

Intelligent Bio Solutions Inc.

$1.6M

ISPC

iSpecimen Inc.

$437K

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.